Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $6.0 million.

  • Maravai Lifesciences Holdings' Depreciation & Amortization (CF) rose 1845.76% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 1976.71%. This contributed to the annual value of $20.9 million for FY2024, which is 6201.55% up from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Depreciation & Amortization (CF) is $6.0 million, which was up 1845.76% from $6.0 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Depreciation & Amortization (CF) high stood at $6.0 million for Q3 2025, and its period low was $1.3 million during Q1 2021.
  • For the 5-year period, Maravai Lifesciences Holdings' Depreciation & Amortization (CF) averaged around $3.4 million, with its median value being $2.8 million (2023).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Depreciation & Amortization (CF) plummeted by 2572.44% in 2021 and then soared by 13009.62% in 2024.
  • Maravai Lifesciences Holdings' Depreciation & Amortization (CF) (Quarter) stood at $1.7 million in 2021, then rose by 14.38% to $2.0 million in 2022, then surged by 97.09% to $3.9 million in 2023, then skyrocketed by 40.16% to $5.5 million in 2024, then grew by 8.36% to $6.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $6.0 million in Q3 2025, compared to $6.0 million in Q2 2025 and $5.7 million in Q1 2025.